India
· Delayed Price · Currency is INR Eris Lifesciences Statistics
Total Valuation
NSE:ERIS has a market cap or net worth of INR 192.94 billion. The enterprise value is 221.92 billion.
| Market Cap | 192.94B |
| Enterprise Value | 221.92B |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | Feb 13, 2025 |
Share Statistics
NSE:ERIS has 136.13 million shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 136.13M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 60.50% |
| Owned by Institutions (%) | 23.99% |
| Float | 40.74M |
Valuation Ratios
The trailing PE ratio is 58.62 and the forward PE ratio is 38.80. NSE:ERIS's PEG ratio is 1.29.
| PE Ratio | 58.62 |
| Forward PE | 38.80 |
| PS Ratio | 7.08 |
| PB Ratio | 6.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.29 |
Enterprise Valuation
| EV / Earnings | 67.38 |
| EV / Sales | 8.15 |
| EV / EBITDA | 26.06 |
| EV / EBIT | 35.57 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.86 |
| Debt / EBITDA | 3.21 |
| Debt / FCF | n/a |
| Interest Coverage | 2.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.50% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.52M |
| Profits Per Employee | 909,815 |
| Employee Count | 3,620 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.53% in the last 52 weeks. The beta is 0.27, so NSE:ERIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +68.53% |
| 50-Day Moving Average | 1,279.65 |
| 200-Day Moving Average | 1,275.26 |
| Relative Strength Index (RSI) | 65.24 |
| Average Volume (20 Days) | 207,472 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ERIS had revenue of INR 27.24 billion and earned 3.29 billion in profits. Earnings per share was 24.18.
| Revenue | 27.24B |
| Gross Profit | 20.46B |
| Operating Income | 6.24B |
| Pretax Income | 4.37B |
| Net Income | 3.29B |
| EBITDA | 8.40B |
| EBIT | 6.24B |
| Earnings Per Share (EPS) | 24.18 |
Balance Sheet
The company has 2.43 billion in cash and 27.35 billion in debt, giving a net cash position of -24.92 billion or -183.08 per share.
| Cash & Cash Equivalents | 2.43B |
| Total Debt | 27.35B |
| Net Cash | -24.92B |
| Net Cash Per Share | -183.08 |
| Equity (Book Value) | 31.77B |
| Book Value Per Share | 203.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.10%, with operating and profit margins of 22.90% and 12.09%.
| Gross Margin | 75.10% |
| Operating Margin | 22.90% |
| Pretax Margin | 16.05% |
| Profit Margin | 12.09% |
| EBITDA Margin | 30.84% |
| EBIT Margin | 22.90% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.35, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 7.35 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.03% |
| Shareholder Yield | 0.55% |
| Earnings Yield | 1.71% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |